6I45

Crystal structure of I13V/I62V/V77I South African HIV-1 subtype C protease containing a D25A mutation

6I45 の概要

• エントリーDOI: 10.2210/pdb6i45/pdb
• 分子名称: Protease, SODIUM ION, DI(HYDROXYETHYL)ETHER, ... (4 entities in total)
• 機能のキーワード: hiv, aids, human, protease, hydrolase, apo
• 由来する生物種: Human immunodeficiency virus 1
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 10837.87

構造登録者

Sherry, D.,Pandian, R.,Achilonu, I.A.,Dirr, H.W.,Sayed, Y. (登録日: 2018-11-09, 公開日: 2020-02-26, 最終更新日: 2024-01-24)

主引用文献

Sherry, D.,Pandian, R.,Sayed, Y.
Non-active site mutations in the HIV protease: Diminished drug binding affinity is achieved through modulating the hydrophobic sliding mechanism.
Int.J.Biol.Macromol., 217:27-41, 2022

PubMed Abstract: The global HIV/AIDS epidemic still currently affects approximately 38 million individuals globally. The protease enzyme of the human immunodeficiency virus is a major drug target in antiviral therapy, however, under the influence of reverse transcriptase and in the context of drug pressure, the rapid PR mutation rate contributes significantly to clinical failure. The set of cooperative non-active site mutations, I13V/I62V/V77I, have been associated with reduced inhibitor susceptibility and are the focus of the current study. When compared to the wild-type protease the mutant protease exhibited decreased binding affinities towards ATV and DRV by 64- and 12-fold, respectively, and decreased the overall favourable Gibbs free energy for ATV, DRV, RTV and SQV. Moreover, these mutations decreased the thermal stability of the protease when in complex with ATV and DRV by approximately 6.4 and 4.2 °C, respectively. The crystal structure of the mutant protease revealed that the location of these mutations and their effect on the hydrophobic sliding mechanism may be crucial in their role in resistance.

PubMed: 35817239
DOI: 10.1016/j.ijbiomac.2022.07.033

実験手法

X-RAY DIFFRACTION (1.8 Å)